Hepatology

Multicentre study in South America suggests MASLD is a leading cause of cirrhosis, highlighting rising metabolic risk factors and gender-balanced insights.

Abnormal Wnt signalling may drive a rare, high-risk childhood liver cancer and influence chemotherapy response, new research suggests.

Genetically higher FGF21 levels were associated with lower problematic alcohol use, fewer binge episodes, reduced weekly alcohol intake, and lower ARLD risk.

HBV vaccination rates among infants in the USA have fallen by more than 10 percentage points in the past two years.

A new blood test accurately identifies serious scarring in patients with liver disease, a 2026 cohort study has found.

Since high levels of alanine aminotransferase are a significant biomarker of liver injury, this analysis points to the benefits of resistance exercise in patients with MASLD, which led to a noticeable decline in alanine aminotransferase levels.

A new point-of-care fingerstick test detects HBV within one hour, a 2026 diagnostic accuracy study has found.

Unscheduled care attendance data provides an opportunity to identify patients at high risk of liver disease, a 2026 study has found.